Gametocyte production and transmission fitness of African and Asian <i>Plasmodium falciparum</i> isolates with differential susceptibility to artemisinins
The emergence of <i>Plasmodium falciparum</i> parasites partially resistant to artemisinins (ART-R) poses a significant threat to recent gains in malaria control. ART-R has been associated with PfKelch13 (K13) mutations, which differ in fitness costs. This study investigates the gametocyte production and transmission fitness of African and Asian <i>P. falciparum</i> isolates with different K13 genotypes across multiple mosquito species. We tested three ART-sensitive (ART-S) isolates (NF54, NF135, and NF180) and three ART-R isolates (ARN1G, 3815, and PAT-023) for sexual conversion and transmission to <i>Anopheles stephensi, An. gambiae,</i> and <i>An. coluzzii</i>. ART-R levels were quantified <i>in vitro</i> using the Ring-stage Survival Assay (RSA), and the transmission-reducing effects of dihydroartemisinin (DHA) on mature gametocytes were assessed. Results showed that ART-S parasite lines consistently produced gametocytes and transmitted effectively in all three mosquito species. ART-R isolates showed variability: ARN1G maintained high transmission levels, whereas 3815 showed limited transmission potential despite higher sporozoite loads in <i>An. coluzzii</i>. The African ART-R isolate PAT-023 demonstrated low gametocyte commitment but was transmitted efficiently in both <i>An. gambiae</i> and <i>An. coluzzii</i>. DHA exposure reduced mosquito infectivity for all isolates, regardless of K13 genotype. These findings, based on a limited number of field isolates, suggest that ART-R parasites remain transmissible across different <i>Anopheles</i> species. However, ART-R does not appear to confer a direct transmission advantage. This study highlights the complexity of ART-R dynamics and underscores the need for further research to inform malaria control strategies in regions where ART-R parasites are circulating.
Authors
- Chiara Andolina (ORCID: https://orcid.org/0000-0002-3622-6832)
- Melissa D. Conrad (ORCID: https://orcid.org/0000-0002-9984-8030)
- Jordache Ramjith (ORCID: https://orcid.org/0000-0003-4431-7395)
- Susana Campino (ORCID: https://orcid.org/0000-0003-1403-6138)
- Wouter Graumans (ORCID: https://orcid.org/0000-0003-3952-6491)
- Nicholas I. Proellochs (ORCID: https://orcid.org/0000-0003-3750-1135)
- Teun Bousema (ORCID: https://orcid.org/0000-0003-2666-094X)
- Rianne Stoter
- Sachel Mok (ORCID: https://orcid.org/0000-0002-9605-0154)
- Taane Gregory Clark (ORCID: https://orcid.org/0000-0001-8985-9265)
- Leen N. Vanheer (ORCID: https://orcid.org/0000-0002-7680-385X)
- Martin Okitwi (ORCID: https://orcid.org/0000-0003-2712-2174)
- David A. Fidock (ORCID: https://orcid.org/0000-0001-6753-8938)
- Patrick K. Tumwebaze (ORCID: https://orcid.org/0000-0002-5933-1432)
- Didier Ménard (ORCID: https://orcid.org/0000-0003-1357-4495)
- Jan C. van Gemert (ORCID: https://orcid.org/0000-0002-6913-0482)
Institutions
- Radboud University Nijmegen (NL)
- Institut Pasteur (FR)
- Institut Universitaire de France (FR)
- Université Paris Cité (FR)
- Columbia University Irving Medical Center (US)
- Radboud University Medical Center (NL)
- London School of Hygiene & Tropical Medicine (GB)
- Infectious Diseases Research Collaboration (UG)
- Université de Strasbourg (FR)
- Columbia University (US)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1128/aac.01930-24
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases